Home AdisOnline Home Current Issue Previous Issues Published Ahead-of-Print Collections Services Information
Skip Navigation LinksHome > 2001 - Volume 2 - Issue 3 > Drug-Induced Urticaria: Recognition and Treatment
American Journal of Clinical Dermatology:
2001 - Volume 2 - Issue 3 - pp 151-158
Review Article

Drug-Induced Urticaria: Recognition and Treatment

Shipley, Debbie; Ormerod, Anthony D.

Collapse Box

Abstract

Urticaria is the second most common cutaneous manifestation of drug allergy. Drug-induced urticaria is seen in 0.16% of medical inpatients and accounts for 9% of chronic urticaria or angioedema seen in dermatology outpatient departments. Occurring within 24 hours of drug ingestion, it is most commonly caused by penicillins, sulfonamides and nonsteroidal anti-inflammatory drugs.

Drug-induced urticaria is seen in association with anaphylaxis, angioedema, and serum sickness. Diagnosis requires a detailed history, knowledge of the most likely agents sometimes supplemented with in vitro and skin testing. For mild reactions, avoidance of the causative drug and treatment with antihistamines will suffice. For anaphylactic shock, treatment with epinephrine (adrenaline), corticosteroids and antihistamines is required. Patients should be educated to inform medical staff about previous drug reactions, and to avoid these and cross-reacting drugs if possible. Medical staff need to routinely enquire about allergy and avoid unnecessary prescriptions.

Copyright 2001 Adis International

Article Tools

You currently do not have access to this article.

You may need to:

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.